Literature DB >> 21140248

Serum appearance of anti-p53 antibody in triple negative breast cancer.

Tadahiro Nozoe1, Emiko Mori, Mayuko Kono, Tomohiro Iguchi, Takashi Maeda, Akito Matsukuma, Takahiro Ezaki.   

Abstract

BACKGROUND: Significance of serum appearance of anti-p53 antibody in breast cancer has not been discussed fully.
METHODS: The relationship between serum appearance of anti-p53 antibody and the clinicopathological features was investigated on the basis of the data of 42 women with breast cancer who had been treated with surgical resection.
RESULTS: The proportion of tumors with histological grade 3 was significantly higher among tumors with serum appearance of anti-p53 antibody (P = 0.020). The proportion of triple negative tumors was also significantly higher among tumors with serum appearance of anti-p53 antibody (P = 0.003).
CONCLUSIONS: Preoperative appearance of anti-p53 antibody in sera can be correlated with the incidence of triple negative breast cancer and could therefore help identify tumors with aggressive potential.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21140248     DOI: 10.1007/s12282-010-0244-3

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  3 in total

Review 1.  Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer.

Authors:  Aravind Suppiah; John Greenman
Journal:  World J Gastroenterol       Date:  2013-08-07       Impact factor: 5.742

2.  Outcome of triple-negative breast cancer in patients with or without markers regulating cell cycle and cell death.

Authors:  Dong Won Ryu; Chung Han Lee
Journal:  J Korean Surg Soc       Date:  2012-09-25

3.  Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.

Authors:  Michèl Schummer; Jason Thorpe; Maria D Giraldez; Maria Giraldez; Lindsay Bergan; Muneesh Tewari; Nicole Urban
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.